Literature DB >> 8132351

Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes.

B J Johnson1, D N McMurray.   

Abstract

In order to better understand the immunoregulation following Mycobacterium tuberculosis infection, cytokine mRNA induction in response to in vitro infection of human monocytes with live virulent M. tuberculosis H37Rv cocultured with autologous lymphocytes was quantitated by reverse transcriptase-PCR. Induced levels of interleukin 1 beta (IL-1 beta), IL-2, tumor necrosis factor alpha, and gamma interferon (IFN-gamma) were compared among groups of individuals representing three phases of immunity to infection with M. tuberculosis: naive normal control subjects, purified protein derivative (PPD)-reactive normal donors, and individuals with active tuberculosis (TB [diseased]). Levels of IL-1 beta and tumor necrosis factor alpha mRNA in cocultured cells from TB patients were 51 and 45%, respectively, of those obtained in cells from sensitized healthy volunteers and were comparable to those from naive normal donors. Lymphoproliferative responses to M. tuberculosis and induction of the T-cell cytokine IL-2 were predictably high in the cells of PPD-sensitized donors, low in normal naive individuals, and variable among TB patients. In contrast, the induced level of another lymphokine, IFN-gamma, did not follow the pattern seen in IL-2 induction. Infection with live M. tuberculosis induced high levels of IFN-gamma mRNA in lymphocytes of both PPD-sensitized and normal naive donors compared with those of TB patients. Interestingly, polyclonal stimulation with the mitogen concanavalin A induced similar IFN-gamma levels in cells from all three donor groups. The high level of IFN-gamma induced by the infection of monocytes from naive normal donors suggests a role for natural killer (NK) cells in the production of IFN-gamma in this coculture system. This response appears independent of the role performed by T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132351      PMCID: PMC186300          DOI: 10.1128/iai.62.4.1444-1450.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Antimycobacterial functions in bone-marrow-derived macrophages.

Authors:  S H Kaufmann; I E Flesch
Journal:  Res Microbiol       Date:  1990-02       Impact factor: 3.992

Review 2.  Role of the CD28 receptor in T-cell activation.

Authors:  C H June; J A Ledbetter; P S Linsley; C B Thompson
Journal:  Immunol Today       Date:  1990-06

3.  Synergy of tumor necrosis factor with protein kinase C activators on T cell activation.

Authors:  M A Muñoz-Fernández; F X Pimentel-Muiños; M A Alonso; M Campanero; F Sánchez-Madrid; A Silva; J L Alonso; M Fresno
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

Review 4.  Cytokines as communication signals between leukocytes and endothelial cells.

Authors:  A Mantovani; E Dejana
Journal:  Immunol Today       Date:  1989-11

5.  Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis.

Authors:  T Takashima; C Ueta; I Tsuyuguchi; S Kishimoto
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Cellular immunity in current active pulmonary tuberculosis.

Authors:  R Andrade-Arzabe; I V Machado; B Fernandez; I Blanca; R Ramirez; N E Bianco
Journal:  Am Rev Respir Dis       Date:  1991-03

Review 7.  Cellular and molecular aspects of granulomatous inflammation.

Authors:  S L Kunkel; S W Chensue; R M Strieter; J P Lynch; D G Remick
Journal:  Am J Respir Cell Mol Biol       Date:  1989-12       Impact factor: 6.914

8.  IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells.

Authors:  P M Villiger; M T Cronin; T Amenomori; W Wachsman; M Lotz
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

9.  Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection.

Authors:  H Teppler; G Kaplan; K Smith; P Cameron; A Montana; P Meyn; Z Cohn
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

Review 10.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more
  13 in total

1.  Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Jin-Hong Min; Hyun-Kyung Kwak; Min-Sun Hong; Ji-Hye Kong; Soo-Hee Hwang; Seung-Kyu Park; Jason J Leblanc; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

2.  Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

Authors:  C J De Haas; N M de Vos; M R Visser; H Snippe; J Verhoef
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival.

Authors:  R K Chandra
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells.

Authors:  P Méndez-Samperio; E Garcia-Martinez; M Hernandez-Garay; M Solis-Cardona
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patients.

Authors:  B J Johnson; I Estrada; Z Shen; S Ress; P Willcox; M J Colston; G Kaplan
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins.

Authors:  D M Russo; N Kozlova; D L Lakey; D Kernodle
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 7.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis.

Authors:  J M Tramontana; U Utaipat; A Molloy; P Akarasewi; M Burroughs; S Makonkawkeyoon; B Johnson; J D Klausner; W Rom; G Kaplan
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

10.  Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs.

Authors:  G Dai; D N McMurray
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.